Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY)
HRMY Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
6.10%
Analyst Rating:
BUY
Analyst Forecast (1yr):
33.70%
HRMY Stock Analysis
HRMY
PE Ratio:
12.9
HRMY
PEG Ratio:
Not Available
HRMY
Forward EPS Growth (12 month):
0.00%
HRMY
PS Ratio:
2.1
HRMY
PSG Ratio:
Not Available
HRMY
Forward Revenue Growth (12 month):
0.00%
HRMY Articles
No data was found